Original Source(s)
Related Content
This Week’s Biopharma News: Amgen Deepens US Manufacturing Push
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
May 12, 2026
-
7 min
Advanced Crohn’s Therapies Show Similar Safety
Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.
by Doug Brunk
February 19, 2026
-
2 min